Last updated: 2026-09-10 20:13:20. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
STERIS plc (STE) operates in the ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES sector and is listed on NYSE. The stock is currently priced at $212.41, with a market capitalization of $21.30B and a P/E ratio of 26.05. Over the past 52 weeks, its price has ranged from $195.14 to $269.44. This page covers its latest market performance, valuation, price trends and company information.
$21.30B | |
$213.52 | |
$269.44 | |
$19.20 | |
$215.09 | |
488.87K | |
738.39K | |
26.05 | |
$269.44 | |
$195.14 | |
1.18% | |
-- |
STERIS plc (STE) is trading at $212.43 in after-hours trading as of 2026-09-10 19:56:51, down 1.24% ($2.66) from the regular-session close of $215.09.
After-hours trading shows how investors are pricing STE after the regular session closes. The current after-hours price is below the regular-session close, indicating cautious after-hours sentiment.
Over the past seven days, STERIS plc (STE) moved from $232.64 to $212.41, representing a decline of 8.70% ($20.23).
The stock traded between $211.39 and $236.09 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 592.09 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 23.2%
STE is currently trading at $212.41, placing it 23.2% of the way from its 52-week low of $195.14 to its 52-week high of $269.44. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 20% from Applied Sterilization Technologies, or AST, and 10% from life sciences services after the divestment of its dental products business.
| Industry | ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES |
| Employees | 17937 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of STERIS plc (STE) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.